The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 01, 2021

Filed:

Dec. 20, 2016
Applicants:

Yaizu Suisankagaku Industry Co., Ltd., Yaizu, JP;

General Incorporated Association Pharma Valley Project Supporting Organization, Mishima, JP;

Inventors:

Mai Ohba, Shizuoka, JP;

Takayuki Ando, Shizuoka, JP;

Akira Asai, Shizuoka, JP;

Naohisa Ogo, Shizuoka, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/352 (2006.01); A23L 33/105 (2016.01); A61K 31/045 (2006.01); A61K 36/82 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A23G 1/00 (2006.01); A61L 2/00 (2006.01); A23G 3/48 (2006.01); A23G 4/06 (2006.01); A61K 9/68 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A23G 1/0013 (2013.01); A23G 1/0036 (2013.01); A23G 1/0046 (2013.01); A23G 1/0056 (2013.01); A23G 3/48 (2013.01); A23G 4/068 (2013.01); A23L 33/105 (2016.08); A61K 9/006 (2013.01); A61K 9/0014 (2013.01); A61K 9/0056 (2013.01); A61K 9/0058 (2013.01); A61K 9/08 (2013.01); A61K 31/045 (2013.01); A61K 36/82 (2013.01); A61K 47/10 (2013.01); A61L 2/0088 (2013.01); A23V 2002/00 (2013.01);
Abstract

Provided are: a composition having an excellent anti-norovirus effect; use of a theaflavin compound for the preparation of the composition; and a method for preventing infection with a norovirus using a theaflavin compound. A theaflavin compound is used as an active ingredient for preventing infection with a norovirus. The theaflavin compound is preferably used together with an alcohol. The theaflavin compound is preferably one or more members selected from the group consisting of theaflavin, theaflavin-3-O-gallate, theaflavin-3'-O-gallate and theaflavin-3,3′-O-digallate that are derived from tea components.


Find Patent Forward Citations

Loading…